Results for "Specialty Pharmaceutical Distribution Facts, Figures, and Trends"
The First 90 Days of COVID-19: Lessons Learned
The emergence of COVID-19 marked the beginning of a public health crisis the scale of which we have never seen. Amid this unprecedented challenge, the pharmaceutical supply chain — powered by distributors — quickly adapted and adjusted to the global pandemic, protecting the steady supply of critical, lifesaving medicines to hospitals, pharmacies, providers and patients.
HDA Research Foundation Announces 2022–2023 Karen J. Ribler Supply Chain Scholars
The HDA Research Foundation today announced the four recipients of its graduate-level Karen J. Ribler Scholarship.
HDA Issues Policy Platform Addressing Drug Shortages
HDA and its pharmaceutical distributor members released a policy agenda to combat drug shortages, centering around three core themes: federal coordination, strategic investment and end-to-end stabilization of the generic drug supply chain.
HDA Unveils Redesigned HDA.org
The Healthcare Distribution Alliance (HDA) today launched a next-generation website, located at HDA.org. The website features a bright, contemporary design and intuitive functionality with member database integration and a resource-rich “Industry Hub.”